Paxlovid could slash Covid death rate

Embargoed until: Publicly released: 2023-03-18 02:00

International

Photo: Julia Prado/MS via Flickr

If more eligible people took Paxlovid, the number of Covid-19 deaths could be halved, new modelling from US researchers suggests. They estimated the Covid-19 antiviral is only being taken by 5% of those eligible to receive it, resulting in the overall Covid-19 hospitalisation and mortality rates being lowered by less than 8%. However when they modelled a scenario where 80% of eligible people took the drug, Covid-19 death rates reduced by 51% and hospitalisation rates dropped by 42%.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research , Web page URL will go live at embargo

Journal/
conference: JAMA Health Forum

Research:Paper

Organisation/s: Brown University, USA

Funder: All authors were supported by the Centers for Disease Control and Prevention through the Council of State and Territorial Epidemiologists (NU38OT000297-02). Dr Saloman was also supported by the National Institute on Drug Abuse (3R37DA01561217S1).

Media Contact/s

Contact details are only visible to registered journalists.